Regenxbio Inc buy BiotechBee
Start price
08.09.24
/
60%
€10.30
Target price
28.02.27
€16.00
Performance (%)
-22.82%
End price
14.12.24
€7.95
Summary
This prediction ended on 14.12.24 with a price of €7.95. The prediction for Regenxbio Inc disappointed with a performance of -22.82%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regenxbio Inc | -1.266% | -1.266% | 30.000% |
| iShares Core DAX® | -3,52 % | -4,99 % | 1,93 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % | 15,43 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % | 29,01 % |
| iShares S&P 500 | -0,82 % | -0,04 % | 10,81 % |
According to BiotechBee what are the pros and cons of Regenxbio Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Regenxbio Inc diskutieren
Buy mit Kursziel 16,0